How long is Upadacitinib usually used?

How long Upadacitinib (Upadacitinib) is generally used depends on the patient's specific situation. Generally speaking, upadatinib is often used to treat diseases such as rheumatoid arthritis, and treatment cycles usually range from a few months to a year. The specific usage time needs to be determined based on the doctor's advice and the patient's condition. If the condition is under control, your doctor may recommend reducing the dose or stopping the medication. Before using the medication, you should consult your doctor and follow your doctor's advice and guidance.

Upapatinib is available15 mg and 30 mg extended-release (ER) tablets for oral administration. Immunizations should be up to date and evaluated for underlying tuberculosis (active or latent) before starting treatment with upadacitinib. Other assessments include liver function, viral hepatitis, and pregnancy status in women of childbearing potential. Concomitant use of upadatinib with other JAK inhibitors, biologic DMARDs, or strong immunosuppressants (azathioprine and cyclosporine) is not recommended.

The original drug Upatinib has been launched in China, and has subsequently entered the scope of Class B medical insurance. Only eligible patients can be reimbursed. Specifications The price of each box of 15mg*28 tablets may be around RMB 3,000. The European version of the original drug sold overseas is priced at more than 20,000 yuan for 15mg*30 tablets (the price may fluctuate due to exchange rates), which is expensive. Cheaper upadatinib generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 15mg*30 tablets produced by Bangladesh pharmaceutical factory is around 900 yuan (the price may fluctuate due to the exchange rate).